What providers need to know about federal funding impacts on cash flow.

What the new legislation could mean for labs, providers, and the future of diagnostic testing.

Withdrawal of LDT Rule Provides Regulatory Clarity and Reimbursement Guidance for Laboratories

The new law brings transformative changes to Medicare, Medicaid, and patient cost-sharing, requiring providers to strategically adapt revenue cycle operations.